ClinicalTrials.gov
ClinicalTrials.gov Menu

Immunogenicity and Safety of 2 Schedules of ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients (MANON 02)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00219362
Recruitment Status : Completed
First Posted : September 22, 2005
Last Update Posted : November 25, 2009
Sponsor:
Information provided by:
Objectif Recherche Vaccins SIDA